natgillin/translations-raw huggingface dataset:
heteroaryl is selected from the group consisting of pyridinyl, pyrazinyl, pyridazinyl, pyrimidinyl, furanyl, thienyl, thiazolyl, oxazolyl, isoxazolyl, imidazolyl, oxadiazolyl, thiadiazoyl, pyrazolyl, tetrazolyl and triazolyl; wherein said heteroaryl is independently optionally substituted with one to three same or different halogens or from one to three same or different substituents selected from F. 
heteroaril se izabire iz skupine koja obuhvaća piridinil, pirazinil, piridazinil, pirimidinil, furanil, tienil, tiazolil, oksazolil, izoksazolil, imidazolil, oksadiazolil, tiadiazoil, pirazolil, tetrazolil i triazolil; gdje je heteroaril nezavisno po izboru supstituiran jednim do tri istih ili različitih halogena ili jednim do tri istih ili različitih supstituenata izabranih između F.
It is possible to provide a source of acoustic energy originating in a location different from that of the receiver. 
Moguće je postaviti akustički izvor koji se ne nalazi na istom mjestu kao i prijemnik.
A process for the preparation of the compounds of Formula I according to claim 1 comprising reacting a compound of Formula II: in which L is a leaving group selected from Cl, Br, I, OSO2CF3, and A, B, R1 and R2 are as defined in Claim 1; with a compound of Formula III: either as the free base or an addition salt hereof; wherein Q, R3, R4, R5, R6 and R7 are as defined in Claim 1; either neat, or in an inert solvent or mixture of solvents, at a temperature between 0 to about 200 °C, optionally in the presence of a base, optionally in the presence of a palladium catalyst, followed by work-up and isolation of the product of Formula I, either as its free base or as an acid addition salt hereof. 
Postupak pripreme spojeva Formule I prema zahtjevu 1 koji obuhvaća reakciju spoja Formule II: u kojem je L odlazeća skupina izabrana između CI, Br, 1, OSO2;CF;, 1A, B, Ri 1 R> su kako je definirano u zahtjevu 1; sa spojem Formule III: ili u obliku slobodne baze ili njezine adicijske soli; gdje Q, Ra, Ra, Rs, Rs 1 R; su kako je definirano u zahtjevu 1; ili čisto ili u inertnom otapalu ili smjesi otapala, pri temperaturi između 0 do oko 200%, po izboru u prisutnosti baze, po izboru paladij katalizatora, nakon čega slijedi dorada 1 izolacija proizvoda Formule I, ili u obliku slobodne baze ili njezine kisele adicijske soli.
wherein is hydrogen, alkyl which may be substituted by A, cycloalkyl which may be substituted by A, alkenyl which may be substituted by A, alkynyl which may be substituted by A, halogen, cyano, aryl OR2, S(O)nR3, NR4R5 or a heterocyclic group which may be substituted by alkyl; 
() naznačen time, da je R! alkil koji može biti supstituiran sa A, cikloalkil koji može biti supstituiran sa A, alkenil koji može biti supstituiran sa A, alkinil koji može biti supstituiran sa A, halogen, cijano, aril, heterociklička skupina, OR", S(O),R*, NR*R';
In some embodiments of the present invention, the individual is a mammal. 
U nekim oblicima prikazanog izuma, pojedinac je sisavac.
For the sake of simplicity, the genome is also referred to as “viral vector genome” or “vector genome”. Backbone Suitable lentiviral vector genomes include those based on Human Immunodeficiency Virus (HIV-1), HIV-2, feline immunodeficiency virus (FIV), equine infectious anemia virus, Simian Immunodeficiency Virus (SIV) and maedi/visna virus. 
Pseudotipizirana čestica lentiviralnog vektora prema bilo kojem od zahtjeva 1-5, pri čemu je genom lentiviralnog vektora odabran iz skupine koja sadrži virus humane imunodeficijencije (HIV-1), HIV-2, virus mačje imunodeficijencije (FIV), virus infektivne anemije kopitara, virus imunodeficijencije kod majmuna (SIV), i maedi/visna virus.
Optically variable printed features on security documents such as bank notes are aimed primarily for authentication of the document by the unaided human eye, through a checking of the feature's spectral reflection properties, i.e. 
Optički varijabilna tiskana svojstva na sigurnosnim dokumentima poput novčanica namijenjeni su prvenstveno za autcntikaciju dokumenta ljudskim okom bez dodatnih pomagala, provjerom svojstava refleksije spcktra koja odlikuju takvo sredstvo, tj.
The layer 12 can be constituted for example by mesh made of synthetic or metallic material, by microstretched metal sheets, by partially compressed synthetic fibers fused by heat, by compressed natural fibers such as hemp or coconut fibers, or by leather. 
Unutarnji potplat za sklapanje u skladu s patentnim zahtjevom 1, naznačen time, da je navedeni nosivi sloj (12) odabran od sljedećih materijala: mreža izrađena od sintetskih ili metalnih materijala, mikronategnute metalne pločice, djelomično stlačena sintetska vlakna rastopljena zagrijavanjem, stlačena prirodna vlakna, poput vlakana konoplje ili kokosa ili koža.
A kit comprising a formulation and instructions indicating that said formulation is to be applied to a tympanic membrane, wherein said formulation is aqueous and comprises a viscogenic agent and moxifloxacin or a salt thereof, wherein said formulation is flowable and has a viscosity less than 100,000 cps, and wherein said formulation, after application to said tympanic membrane, forms a gel that has a yield stress sufficient to maintain said formulation against said tympanic membrane, wherein said formulation allows for transfer of the moxifloxacin across the tympanic membrane and into the middle ear space. 
Vodena formulacija, naznačena time što sadrži viskogeno sredstvo, moksifloksacin, ili njegovu sol, te izopropil- miristat (IPM), gdje je navedena formulacija tekuća i ima viskoznost manju od 100 Pa*s na 25 "C; gdje navedena formulacija, nakon primjene na membranu bubnjića u uhu subjekta, tvori gel koji ima elastičnu čvrstoću dovoljnu za zadržavanje navedene formulacije na membrani bubnjića; 1 gdje navedeni moksifloksacin prolazi kroz membranu bubnjića i u prostor srednjeg uha kada se formulaciju primijenjuje na membranu bubnjića.
The method as described in item27, which comprises a detection or determination of the amount in a first sample at a first point in time and in a further sample at a second point in time and a comparison of the two samples. 
Postupak prema patentnom zahtjevu 10, naznačen time što sadrži detekciju ili određivanje količine u prvom uzorku u prvoj vremenskoj točki i u drugom uzorku u drugoj vremenskoj točki i usporedbu dva uzorka,
A fast reaction with the resin prevents evaporation. 
Brza reakcija sa smolom sprečava isparavanje.
In particular, purified IL-18BP may be used for treatment and/or prevention of psoriasis, psoriatic arthritis, Crohn's Disease, rheumatoid arthritis, liver injury such as alcoholic liver cirrhosis, sepsis, atherosclerosis, ischemic heart diseases, allergies, in particular delayed-type hypersensitivity, and closed head injury, as disclosed in WO9909063, WO0107480, WO0162285, WO0185201, WO02060479, WO02096466, WO03080104, WO02092008, WO02101049, WO03013577. 
Posebice, pročišćeni se IL-18BP može koristiti za liječenje i/ili prevenciju psorijaze, psorijatičnog artritisa, Crohnove bolesti, reumatoidnog artritisa, oštećenja jetre poput ciroze jetre uzrokovane alkoholom, sepse, ateroskleroze, ishemične bolesti srca, alergija, posebice preosjetljivosti odloženog tipa, i zatvorenih povreda glave, kako je navedeno u WO9909063, WO0107480, WO0162285, WO0185201, WO02060479, WO02096456, WO03080104, WO02092008, WO02101049, WO03013577.
The salt of the compound for use according to claim 5, wherein the inflammatory condition is colitis. 
Spoj za uporabu prema zahtjevu 6, naznačen time da upalno stanje je kolitis i/ili Crohnova bolest.
In Figure 16, the openings 1601, 1602 being in closer proximity to each other may be useful for those blended items that have a smaller diameter or that may be poured or strained out of the container 1100 . 
Na Slici 16 otvori 1601, 1602 koji su bliže jedni drugima mogu biti korisni za one izmješane proizvode PATENTNI ZAHTJEVI 1.
As shown in the exemplary embodiment of Figure 1, the container 101 is a bullet-shaped container. 
Kako je prikazano na primjeru ostvarenja na Slici 1, posuda 101 je oblika metka.
The method for certification electronic mail delivery of claim 1, further comprising a step of withdrawing credit from an account of the transmitting user by the data processing unit. The method for certification of electronic mail delivery of claim 1, further comprising an initial step of authenticating the transmitting user. The method for certification of electronic mail delivery of claim 1, wherein the copy of the first electronic message comprises attached data which comprise an invoice and the particular indication inserted comprises a sentence reading: CERTIFIED INVOICE. 
Metoda za potvrđivanje dostave elektronske pošte, u skladu s bilo kojim od prethodnih patentnih zahtjeva, karakterizirana na način da jedinica za obradu (11) povlači neku količinu s računa korisnika pošiljatelja (1). Metoda za potvrđivanje dostave elektronske pošte, u skladu s bilo kojim od prethodnih patentnih zahtjeva, karakterizirana na način da obuhvaća početni korak provjere vjerodostojnosti korisnika pošiljatelja (1) u sustavu potvrđivanja.
D/A converter means (74) in series with the said filter (72). 
- < D/A pretvaračko sredstvo (74) postavljeno u nizu sa spomenutim filterom (72).
A pharmaceutical composition as defined in claim 11 for use in therapy, preferably 
Farmaceutski pripravak, sukladno patentnom zahtjevu 15, za uporabu u terapiji, poželjno
The PD-1 antibody or the antigen-binding fragment thereof according to claim 1, wherein the antibody or the antigen-binding fragment thereof is a chimeric antibody. 
PD-1 protutijelo ili njegov fragment koji se veže na antigen sukladno patentnom zahtjevu 1, pri čemu je to protutijelo ili njegov fragment koji se veže na antigen kimerno protutijelo.
The method as in item 14, wherein the amount of needles (62) or the engraved protruding portions (63) is about 40 - 120 per cm2. 
Postupak prema zahtjevu 11, naznačen time što je količina igala (62) ili ugraviranih izbočenih dijelova (63) oko 40 - 120 po cm".
The part 76 of the heat exchanger 70 is joined via a hinge 78 to the part 77 and can be placed in the closed position. 
Dio 76 izmjenjivača topline 70 je spojen pomoću šarke 78 na dio 77 i može biti postavljen u zatvoreni položaj.
Use according to claim 20, in which said tissue infarct is selected from the group consisting of cardiac and cerebral infarction. 
Primjena prema zahtjevu 20, kod kojo je infarkt tkiva izabran iz grupe koja se sastoji od srčanog i cerebralnog infarkta.
prevention and elimination of disorders due to corticosteroids and NSAIDs; 
- prevencija i eliminacija poremećaja izazvanih kortikosteroidima 1 NSAID-ima;
Item 8. items Upwardly oriented storage according to any one of the previous items, wherein at least a part of a side wall (130, 131, 132) of the storage is movable for providing a modification of the shape of the interior space (110, 112), particularly for providing an increase of the cross section (11, 113) of the interior space in an area proximal to an opening provided for emptying the storage. Item 9. 
Prema gore orijentirano skladište prema bilo kojem od prethodnih patentnih zahtjeva, naznačeno time, što je bar dio bočnog zida (130, 131, 132) skladišta pokretan da bi se omogućila promjena oblika unutrašnjosti (110, 112) skladišnog prostora, posebno za omogućavanje povećanja poprečnog presjeka (11, 113) unutrašnjosti skladišnog prostora u području koje se nalazi u blizini otvora predviđenog za pražnjenje skladišta.
or Rc and Rd together with the N atom to which they are attached form a 4-, 5-, 6-, or 7 membered heterocycloalkyl group, which is optionally substituted with -OH or C1-3 alkyl; 
ili Rc i Rd zajedno sa atomom N za koji su vezani može obrazovati 4-, 5-, 6- ili 7-članu heterocikloalkil grupu koja dalje može biti supstituirana sa -OH ili C1-3 alkil grupom;
R7=an alkyl group, an olefinic group, or an aromatic group; 
R; = alkil skupina, olefin skupina ili aromatska skupina;
Fig. 16 shows the inner part 60 detached from the outer parts 62 and the metal layer 72. 
Slika 16 prikazuje unutarnji dio 60 kada je odvojen od vanjskih dijelova 62 i metalni sloj 72.
N2-(4-cyclopropyl-5-fluoro-6-methyl-2-pyridyl)-5-[3,4-dimethyl piperazin-1-yl]-N4-(2-methyltriazol-4-yl)pyrimidine-2,4-diamine;as well as pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, polymorphs, racemic mixtures, optically active forms and pharmaceutically active derivative thereof. 
-(4-ciklopropil-5-fluoro-6-metil-2-piridil)-5-[3,4-dimetil piperazin-1-il]-N4-(2-metiltriazol-4-il)pirimidin-2,4-diamin; kao i farmaceutske prihvatljive soli, kompleksi, hidrati, solvati, tautomeri, polimorfi, racemati, optički aktivni oblici i njihovi farmaceutski aktivni derivati.
alkyl refers to a straight or branched hydrocarbon chain radical consisting solely of carbon and hydrogen atoms, containing no unsaturation, having from one to twelve carbon atoms. 
HR P20130045 T1 alkil se odnosi na ravni ili razgranati radikal lanca ugljikovodika koji se sastoji isključivo od atoma ugljika i vodika, nije nezasićen, te ima od jedan do dvanaest atoma ugljika.
The method according to claim 25, wherein following addition of 2-((1-methylpropyl)amino)ethanol to the suspension, the suspension is passed through a passage having a suspension throughput regulated as a function of the suspension conductivity. 
Uporaba u skladu s patentnim zahtjevom 17, karakterizirana na način da nakon dodavanja navedenog 2-((1- metilpropil)amino)etanola u navedenu otopinu, otopina prolazi kroz prolaz koji ima protok otopine reguliran kao funkciju vodljivosti otopine.
Method according to claim 1, characterized in that the discharge of the solid component is carried out by: 
Metoda u skladu sa patentnim zahtjevom 1, naznačena time da je pražnjenje čvrste komponente izvedeno pomoću:
The waterproof liner according to claim 23, wherein the expandable watertight device is positioned between two side spongy members. The waterproof liner according to claim 24, comprising a first water leakage detecting chamber, respectively a second chamber for injecting a sealing-material, said first and second chamber being disposed between the expandable watertight member and the side spongy members. 
Vodonepropusna obloga u skladu s patentnim zahtjevom 25, naznačena time, da sadržava prvu komoru za otkrivanje propuštanja vode (46.1), odnosno drugu komoru (46.2) za ubrizgavanje brtvenog materijala, pri čemu se navedena prva i druga komora raspoređene između ekspandirajućeg vodonepropusnog elementa (45) i bočnih spužvastih elemenata (44.1, 44.2).
A method according to claim 1, wherein the flea, tick or fly is selected from the families Ixodidae, Argasidae, Muscidae, or Pulicidae. A method according to claim 1, wherein the flea, tick or fly is selected from Boophilus spp, Rhipicephalus spp, Dermacentor spp, Hyalomma spp, Amblyomma spp, Otobius spp, Ornithodoros spp, Stomoxys spp, or Ctenocephalides spp. 
Farmaceutski pripravak, pri čemu se pripravak sastoji od 5-kloro-N-[2-[4-(2-etoksietil)-2,3-dimetillfenoksiletil]-6-etil-4-pirimidinamina ili njegove soli kao aktivnog spoja u jediničnom obliku doziranja, naznačen time da je namijenjen upotrebi za liječenje sisavca koji nije čovjek zaraženog ektoparazitom, pri čemu je ektoparazit odabran od Boophiliis spp, Rhipicephalus spp, Dermacentor spp, Hyalomma spp, Amblyomma spp, Otobius spp, Ornithodoros spp, Damalinia spp, Stomoxys spp, Bovicola spp, reda Diptera ili Ctenocephalides spp, te pri čemu je sisavac koji nije čovjek odabran od stoke i domaćih sisavaca.
The cartridge (1) according to claim 1, wherein said plastic films (33, 23) are coupled to the respective aluminum films (32, 22) through lamination by means of a respective layer of adhesive. 
Kapsula (1) prema bilo kojem od prethodnih zahtjeva, pri čemu su spomenuti plastični filmovi (33, 23) spojeni sa odgovarajućim aluminijskim filmovima (32, 22) laminiranjem odgovarajućeg sloja adheziva ili drugim sustavom.
The method of claim 15, comprising conversion of the alcohol group of the cis-alcohol of formula Va to a suitable leaving group LG resulting in the compound of formula VI. 
Postupak prema zahtjevu 11, obuhvaća pretvorbu alkoholne skupine u cis-alkoholu formule Va u odgovarajuću odlazeću skupinu LG, čime se dobiva spoj formule VI. [image]
VLP according to any one of the above claims, wherein the drug is selected from the group consisting of a CNS active compound, a detectable agent such as a radionuclide, a protein, a peptide and a nucleic acid, in particular selected from the group consisting of nucleic acids encoding a desired protein such as mRNA, cDNA, a plasmid or vector; inhibitory nucleic acids such as siRNA or miRNA; and nucleic acids having catalytic activity such as a ribozyme. 
Virusu slična čestica (VLP) za uporabu sukladno bilo kojem od gore navedenih patentnih zahtjeva, pri čemu je lijek odabran iz skupine koja se sastoji od CNS aktivnog spoja, agensa koji se može detektirati kao što je radionuklid, protein, peptid i nukleinska kiselina, posebno odabrana skupina koja se sastoji od nukleinske kiseline koje kodiraju željeni protein kao što je mRNK, cDNK, plazmid ili vektor; inhibirajuće nukleinske kiseline kao što je RNK ili miRNK; 1 nukleinske kiseline koje imaju katalitičku aktivnost kao što je ribozim.
The golf club swing training apparatus recited in claim 1 wherein said slide mechanism comprises a pair of parallel linear glide blocks in spaced relation and a pair of fastener assemblies compressing the blocks toward one another. 
Uređaj u skladu s patentnim zahtjevom 1, naznačen time što klizni mehanizam sadrži par razmaknutih paralelnih linearnih graničnika vodilice (36, 40) i par sklopova za pričvršćivanje (48, 49), koji pritišću graničnike jedan prema drugom.
The device according to claim 1, wherein the device is configured to regulate a temperature of the preservation liquid within a range from 1 to 40 degrees Celsius. The device according to claim 1, wherein the endothelial lid includes a first section comprising the second hole and a second section that is transparent. 
Uređaj (1) u skladu s bilo kojim od patentnih zahtjeva 1 do 7, naznačen time što je uređaj prilagođen za održavanje temperature konzervacijske tekućine na temperaturi od 1 do 40 "C, primjerice na fiziološkoj temperaturi rožnice.
a composition suitable for control of diseases caused by phytopathogens comprising (A) a compound of formula I 
Pripravak koji je pogodan za nadzor bolesti uzrokovanih fitopatogenim organizmima uključujući (A) spoj formule
Important properties of polymorphic forms of a drug, i.e. 
Važna svojstva polimorfnih oblika lijeka, tj.
and A2 are independently selected from the group consisting of hydrogen and optionally substituted alkyl; 
VI naznačen time: da se Aj i A, neovisno biraju iz skupine koju čine vodik 1 opcionalno supstituirani alkil;
A winder unit (1) in accordance with any preceding claim, wherein the unit is repositioned between a first position proximate an upper corner of the glazing panel and a second position proximate an opposed upper corner of the glazing panel. A winder unit in accordance with any preceding claim, the unit having: 
Jedinica za namatanje, namijenjena upotrebi u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačena time što se navedenu jedinica premješta između prvog položaja u blizini gornjeg ugla prozorskog panela i drugog položaja u blizini nasuprotnog gornjeg ugla prozorskog panela.
The packaging plank according to claim 8, wherein said containers are selected from the group consisting of cans, food cans, glass jars, cardboard boxes of the carton or Tetrapack® type. 
Uzorak ambalažnog pakiranja u skladu s bilo kojim od zahtjeva 12 do 14, naznačen time, da su navedeni spremnici (2) odabrani iz skupine koja se sastoji od limenki, konzervi, staklenki, kartonskih kutija tetraedarskog tipa ili tetrapaka®.
The isolated antibody, or antigen binding portion thereof, of claim 25 comprising two heavy chains and two light chains, wherein each of the heavy chains consists of the amino acid sequence of SEQ ID NO: 133 or 189 and each of the light chains consists of the amino acid sequence of SEQ ID NO: 102. 
Izolirano antitijelo iz patentnog zahtjeva 7, gdje konstantna regija teškog lanca dalje sadrži humani lgG1 CH2 domenu koja sadrži aminokiselinske supstitucije A330S i P331S, u skladu sa EU indeksom Kabat sistema, u odnosu na CH2 domenu humanog IgG1 divljeg tipa (SEQ ID NO: 137).
The solution is then seeded with purified crystalline form II of N-benzoyl-staurosporine B6 suspended in ethanol. 
(b) kultiviranje otopine s kristalnim oblikom II od N-benzoil-staurosporina;
A CXCR5 antagonist, which binds CXCR5, for use in the treatment of a CXCR5 disease that is pancreatic cancer, colon cancer, bladder cancer, T cell leukemia, B cell leukemia, lupus, Sjoren's Syndrome, myasthenia gravis, multiple sclerosis, ulcerative colitis, rheumatoid arthritis, psoriatic arthritis, chronic inflammatory diseases, or grafts undergoing rejection, wherein the antagonist comprises the antibody or antigen binding fragment thereof of any one of claims 1-5, or 9 and wherein the CXCR5 disease is preferably rheumatoid arthritis. 
11. Antagonist CXCRS, koji veže CXCRS5, namijenjen upotrebi u liječenju bolesti CXCRS koja je rak gušterače, rak debelog crijeva, rak mjehura, leukemija T stanica, leukemija B stanica, lupus, Sjogrenov sindrom, mijastenija gravis, multipla skleroza, ulcerozni kolitis, reumatoidni artritis, psorijatični artritis, kronične upalne bolesti ili transplantati koji se odbacuju, pri čemu antagonist obuhvaća protutijelo ili njegov fragment koji veže antigen prema bilo kojem od zahtjeva 1-5 ili 9 1 pri čemu je CXCRS bolest poželjno reumatoidni artritis.
A garment comprising the device of claim 12. 
Odjeća naznačena time da sadrži uređaj iz zahtjeva 12.
The highest concentration tested was 10 mM, 5000 µg/ml, or the limits of solubility. 
Najviša testirana koncentracija bila je 10 mM, 5000 ug/ml, ili granice topljivosti.
The device of claim 1, further comprising a cell delivery device comprising at least one cell infusion tube configured to be positioned within the outer plug and configured to deliver cells to the chamber of the device. 
Uređaj prema zahtjevu 2, da nadalje sadrži uređaj za isporuku stanica koji sadrži najmanje jednu cijev za infuziju stanica konfiguriranu tako da se nalazi unutar vanjskog čepa.
Carbohydrates, salts of alkali and alkaline-earth metals and iodine intercalated into them, characterized in that the proteins and/or polypeptides of ion nanostructured complex contain at least one chain-terminal amino acid with electron-donor functional groups. Antibacterial agent under p. 
Antibakterijsko sredstvo, naznačeno time, da obuhvaća ionski nanostrukturirani kompleks koji je sastavljen od proteina i/ili polipeptida, ugljikohidrata, soli alkalijskih metala ili soli zemnoalkalijskih metala te joda koji se umeće u unutrašnjost njihovih struktura, pri čemu proteini i/ili polipeptidi od ionskog nanostrukturiranog kompleksa, sadrže najmanje jedan završetak amionokiselinskog lanca s funkcionalnim elektron-donorskim skupinama.
First, the use of such green log sections has the advantage that the wood is still essentially untreated, and the probability is decreased that in the further processing changes of the material result, such as staining. 
Prvo, upotreba takvih dijelova zelenog debla ima tu prednost da drvo uglavnom još nije obrađivano i smanjuje se vjerojatnost da se dogode promjene materijala u daljnjim postupcima, takve promjene kao što je gubitak boje ili sjaja.
wherein the chiral carbon atom designated by the numeral 2 is in the syn configuration with respect to the chiral carbon atom designated by the numeral 1. 
gdje se kiralni atom ugljika koji je označen s brojkom 2, nalazi u syn-konfiguraciji u odnosu na kiralni atom ugljika koji je označen s brojkom 1.